Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.
Оборотен капитал
2022
2021
2020
2019
2018
2017
Парични средства и инвестиции
98997.53
174643.45
125511.92
104432.94
33648.52
34458.09
Приемници
0.00
0.00
0.00
0.00
0.00
0.00
Инвентарна книга
105256.82
90686.54
96744.02
78029.32
5516.87
5374.37
Други
2082.07
1956.53
2120.51
4030.23
491.11
0.00
Общо текущи активи
357916.64
367618.43
290572.46
263282.50
54890.86
58316.55
Acc Payable
49010.77
41875.18
38316.29
44363.74
3558.93
3289.82
Краткосрочен дълг
255336.26
241763.84
197138.31
208514.96
67327.25
65971.56
Други текущи пасиви
222377.10
255666.39
104792.46
71520.49
10784.76
12340.37
Текущи пасиви
526724.13
539305.41
340247.06
324399.18
81670.94
81601.75
Капиталова структура
Всички числа в милиони
Общо активи
283774,19 щ.д.
Общо задължения
110782441000,00 щ.д.
Дългосрочен дълг
11500,00 щ.д.
Парични средства и екви
17705425000,00 щ.д.
Goodwill
0,00 щ.д.
Неразпределена печалба
85268944000,00 щ.д.
Обикновени акции
11540,40 щ.д.
Стойност на предприятието
55,58 щ.д.
Дивиденти за маса
Години
Q1
Q2
Q3
Q4
Общо
2002
242.155
0.000
0.000
0.000
242.155
2003
242.155
0.000
0.000
0.000
242.155
2004
242.155
0.000
0.000
0.000
242.155
2005
339.016
0.000
0.000
0.000
339.016
2006
387.447
0.000
0.000
0.000
387.447
2007
387.447
0.000
0.000
0.000
387.447
2008
503.681
0.000
0.000
0.000
503.681
2009
440.721
0.000
0.000
0.000
440.721
2010
566.642
0.000
0.000
440.721
1007.363
2011
0.000
0.000
0.000
566.642
566.642
2012
0.000
0.000
0.000
472.201
472.201
2013
0.000
0.000
0.000
503.681
503.681
2014
0.000
0.000
0.000
629.602
629.602
2015
0.000
0.000
0.000
944.403
944.403
2016
0.000
0.000
0.000
136.054
136.054
2017
0.000
0.000
0.000
181.406
181.406
2018
0.000
0.000
0.000
190.476
190.476
2019
0.000
0.000
0.000
95.238
95.238
2020
0.000
0.000
0.000
100.000
100.000
2021
0.000
0.000
0.000
100.000
100.000
2022
0.000
0.000
0.000
100.000
100.000
Подобни запаси
Може да се интересувате и от
PILL.CN
Canntab Therapeutics Limited.
0.015 CAD
CNQ
CRON
Cronos Group Inc..
1.75 USD
NASDAQ
RMTI
Rockwell Medical, Inc..
3.32 USD
NASDAQ
ATNX
Athenex, Inc..
0.2031 USD
NASDAQ
SCYX
SCYNEXIS, Inc..
2.5 USD
NASDAQ
RDHL
RedHill Biopharma Ltd..
2.32 USD
NASDAQ
CPIX
Cumberland Pharmaceuticals Inc..
1.59 USD
NASDAQ
PRPH
ProPhase Labs, Inc..
9.49 USD
NASDAQ
OGI
OrganiGram Holdings Inc..
0.371 USD
NASDAQ
BOI.PA
Boiron SA.
37.9 EUR
EURONEXT
Frequently Asked Question
Why is your stock tool better than competitors?
Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms
Can I trust the data on your website and where do they come from?
Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.
Who creates the content on your website and is it approved by experts in finance and investing?
All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.
What problem does your tool solve? Who is the target audience for your tool
Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.
Why did you decide to create your tool?
While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.
What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?
Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee
Who is your team and do they have enough experience?
You can read about our team here, or you can contact us at [email protected] for more information.
